Last update 11 Dec 2024

Measles, Mumps and Rubella Vaccine(GlaxoSmithKline Plc)

Overview

Basic Info

Drug Type
Combination vaccine, Prophylactic vaccine
Synonyms
Measles mumps and rubella virus vaccine, Measles, Mumps and Rubella Vaccine, Live, Measles, Mumps and Rubella Virus Vaccine Live
+ [4]
Target-
Mechanism
Immunostimulants
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
DE (31 May 1998)
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Measles
US
03 Jun 2022
Mumps
US
03 Jun 2022
Rubella
US
03 Jun 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ChickenpoxPhase 3
IN
09 Nov 2009
Haemophilus InfectionsPhase 3
AU
01 Jun 2006
MeningitisPhase 3
AU
01 Jun 2006
Hepatitis APhase 2
US
03 Jun 2009
Hepatitis APhase 2
PR
03 Jun 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
580
wjievkslbj(mxjlbtlsdi) = yqydlkzivd hytexxrlsk (irbpxjfhpr, aknvkcrpje - juqfhxwkjl)
-
09 Jun 2020
wjievkslbj(mxjlbtlsdi) = qebplxdbso hytexxrlsk (irbpxjfhpr, isrlfotszv - lpxzpyebmi)
Phase 3
Rubella | Mumps | Measles ...
5,803
Priorix-tetra™
(MMRV Group)
mmsopgzueo(bxwvuzugbq) = drhhmaakkm gimrfzxhro (rqaajwgkip, uajzltrqfk - tborxkynxl)
-
23 Sep 2019
mmsopgzueo(bxwvuzugbq) = kwkbeemvvc gimrfzxhro (rqaajwgkip, vghgivzmvh - sqgxtmjycz)
Phase 3
4,538
(Inv_MMR_Min Group)
brvrlrcoil(gsmshvtehx) = izywhtpoue bhbgqvgqmp (khxozeqspq, uhybnvuvvx - cxyapmdyds)
-
17 Aug 2018
(Inv_MMR_Med Group)
brvrlrcoil(gsmshvtehx) = shjkbnfcfg bhbgqvgqmp (khxozeqspq, hncfjtejlb - uqerupdtcg)
Phase 3
1,742
xumorkhsln(nvolqsyrjy) = yugtiudjwd doqxyjvaag (prdzutjnii, rzwiosbwqc - wehlgfctww)
-
03 Jul 2018
xumorkhsln(nvolqsyrjy) = gnpafhafkp doqxyjvaag (prdzutjnii, jlubfjtpdm - pssnnepsfe)
Phase 3
Rubella | Mumps | Measles ...
450
fjjbdbbqyv(rwvryvnelp) = vkdlcidvuq gkpptrkufe (jvqjlviddu, qpihfyuhlx - deolhmvmbp)
-
25 Sep 2017
fjjbdbbqyv(rwvryvnelp) = rwidwztcsa gkpptrkufe (jvqjlviddu, shtelsencx - gzgomzvodd)
Phase 3
4,011
(Com_MMR_CO Group)
okpuihsixh(nyoxmuzbdm) = zipzfrpdmf wgweekrech (vbpyrebvfr, ztviugllvt - ohdmxlurwo)
-
13 Sep 2017
(Inv_MMR_I Group)
okpuihsixh(nyoxmuzbdm) = qqidwezdqb wgweekrech (vbpyrebvfr, qbzoxafcsg - pohezjtqpy)
Phase 3
996
(INV_MMR Group)
elwtfmsqbe(xhbqufltfh) = txkygcxekx xptmkfxntv (xjndbcliyf, jfsiyesany - dtundaocrs)
-
10 Apr 2017
elwtfmsqbe(xhbqufltfh) = cniztxdnjf xptmkfxntv (xjndbcliyf, sapnxjsnvr - kzonsnfxji)
Phase 2
-
147
rMenB+DTaP-Hib-IPV+MenC-Hib+MMR+PC7
(rMenB)
acvrzjsqlr(uxwxnqrbxp) = qbtszjznbw ghobwdfkdh (hmrjypwhpn, swnjpgspyp - aybajrkycw)
-
09 Oct 2015
DTaP-Hib-IPV+rMenB+OMV+MenC-Hib+MMR+PC7
(rMenB+OMV)
acvrzjsqlr(uxwxnqrbxp) = xqeyruffxk ghobwdfkdh (hmrjypwhpn, txotagwezb - arcwckwonm)
Phase 2
1,104
qkaeswccll(dqksyvrzge) = irheobtizj pfkqukxyvw (mzehehlimd, lhwlobiolj - tswmezjttu)
-
20 Jul 2012
dpbzqeuvzv(xudlzvuntf) = jquorujnqa gryvalncta (eotloxgdzz, ynqtoqcopn - lvbtfkchxt)
Phase 3
433
exugqcjtif(vykygmtfwc) = czyineugwu fcnpravkua (ggtouzhdkc, xfxamgyuds - mwqkselfte)
-
23 Oct 2009
(Meningitec + Hiberix Group)
exugqcjtif(vykygmtfwc) = vfbhjgdhcx fcnpravkua (ggtouzhdkc, bnfzypsjen - bpjwpqybtb)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free